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Advances in Textile
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Abstract
	 The	aim	of	the	chapter	is	to	state	different	new	possibilities	that	textile	
substrates	offer	for	more	specialized	functions	as	Biomedical	devices,	Cos-
metics,	Skin	treatment,	and	which	are	the	mechanisms	involved	in	such	new	
applications.	How	to	quantify	the	transport	phenomena	from	the	substrate	to	
the	skin,	or	to	surrounding	different	medium,	in	which	they	have	to	be	used.
	 Textiles	are	covering	80%	of	the	human	body	and	a	big	percentage	of	
that	is	in	close	contact	with	skin.	If	the	system	of	vehiculization	of	the	active	
principles	is,	carefully,	designed,	the	reservoir	effect	of	the	polymeric	chains	
of	fibers	can	play	a	very	 interesting	 role	 in	 the	delivery	of	 the	active	prin-
ciple.	
	 Microencapsulation,	 lipidic	 aggregates	 and	 nanofibers,	 have	 shown	
very	promising	experimental	results.	These	results	will	help	to	other	research-
ers	to	develop,	more	accurate	systems,	which	will	valorize	textile	substrates,	
fibers	and	tissues	for	the	use	in	more	sophisticated	fields.
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1. Introduction 
1.1. Textile substrates, as “active systems”
	 Biofunctional	textiles	are	the	textiles	with	smart	and	new	properties	and	added	value,	
especially	related	to	comfort	or	specific	functions.	Such	textiles	constitute	 the	basis	for	 the	
delivery	system	of	cosmetic	or	pharmaceutical	substances	when	the	textile	comes	into	contact	
with	the	skin.	As	most	of	the	human	body	is	covered	with	some	sort	of	textile,	the	potential	of	
biofunctional	textiles	is	considerable.	Textiles	that	have	functional	properties	for	the	skin	have	
been	studied	and	patented	in	recent	years	[1,2].
	 Since	time	immemorial,	textile	fabrics	have	been	improved	to	assist	skin	function	by	
ensuring	homeostasis	of	the	whole	body.	Practical	functions	of	clothing	include	providing	the	
human	body	with	protection	against	the	weather	–strong	sunlight,	extreme	heat	or	cold,	and	
rain	or	snow	–	and	against	insects,	noxious	chemicals	and	contact	with	abrasive	substances.	
Clothing	offers	protection	against	anything	that	might	injure	the	naked	human	body.	This	is	
because	textiles	have	always	been	considered	as	a	“second skin”	for	human	beings.
	 As	a	result	of	new	technologies,	technical	bioactive	or	biofunctional	textiles	are	currently	
being	produced.	Such	fabrics	are	able	to	absorb	substances	from	the	skin	or	release	therapeutic	
or	cosmetic	compounds	to	it.	The	textile	industry	together	with	medical	knowledge	has	paved	
the	way	for	enriching	the	use	of	textile	fabrics	because	of	their	interaction	with	the	skin	[3].
	 Percutaneous	absorption	is	an	interdisciplinary	subject	that	is	relevant	to	a	number	of	
widely	divergent	fields.	Transdermal	devices	may	be	considered	as	one	of	the	precursors	of	
biofunctional	 textiles	given	 that	 they	deliver	a	compound	with	a	 therapeutic	effect	 into	 the	
body	[4,	5].
	 Bioactive	textiles	are	new,	innovative	textile	products	that	are	pushing	back	the	boundaries	
of	textile	applications.	They	can	act	as	“reservoir	systems”	and	are	able	to	continually	release	
controlled	doses	of	active	substances	from	the	textile	to	the	skin.	Several	active	compounds	
have	 been	 applied	 onto	 textiles	 using	 different	 vehicles	 as	micro	 or	 nanocapsules	 in	 order	
to	improve	the	fixation	on	the	fabric	and	the	progressive	and	effective	release	of	the	active	
principle	into	the	different	skin	layers	(stratum corneum,	epidermis	or	dermis).
1.2. Mechanisms involved and their quantification 
1.2.1. Transdermal drug release into the skin
	 Transdermal	drug	release	is	a	viable	administration	route	for	powerful,	low-molecular-
weight	therapeutic	agents	that	must	be	precise	in	its	control	of	drug	administration.	The	system	
should	ensure	the	required	doses	and	avoid	the	minimum	toxic	concentration	[6].	This	strategy	
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is	 especially	 recommended	 for	many	 drugs	 that	 are	 difficult	 to	 take	 because	 they	must	 be	
delivered	slowly	over	a	prolonged	period	to	have	a	beneficial	effect.	For	instance,	 the	drug	
release	modelling	of	biodegradable	polymeric	systems	as	encapsulation	technologies	in	textiles	
has	not	yet	progressed	appreciably	due	to	its	high	complexity.
	 Transdermal	administration	also	can	take	advantage	of	chemical	and	physical	strategies	
that	 can	 improve	 skin	 permeability	 and	 allow	 for	 drug	 penetration	 [7-14].	 Specifically,	
transdermal	 drug	 delivery	 is	 a	 viable	 administration	 route	 for	 powerful,	 low-molecular-
weight	therapeutic	agents	that	either	can	or	cannot	withstand	the	hostile	environment	of	the	
gastrointestinal	tract	[6].	Regardless	of	the	necessity	for	physical-chemical	enhancement,	for	
the	 reliable	 and	 effective	 design	 of	 transdermal	 delivery	 systems,	 knowledge	 of	 the	 skin’s	
structure	(see	Figure 1)	and	its	properties	is	fundamental	[9].	
	 Empirical	analysis	of	the	permeation	of	drugs	through	the	skin	is	based	on	approaches	
such	as	a	neural	network	modelling	to	predict	the	permeability	of	skin	[15-22].
	 Guy	and	Hadgraft	[23]	developed	a	mathematical	model	for	investigating	the	effect	of	
the	variation	in	thickness	during	drug	release	through	the	skin.	Accordingly,	the	experimental	
permeation	 data	 are	 fitted	 by	 the	 following	 equation,	 which	 suitable	 for	 describing	 the	
permeation	of	a	drug	through	a	thin	membrane:
																																																												(1)
	 where	Mt	 is	 the	total	amount	of	drug	that	passes	through	the	layers	of	skin,	Ls is the 
thickness	of	 the	stratum corneum	 and	L
0
	 the	 formulation	 thickness	over	period	 t.	Ds is the 
diffusion	coefficient	of	the	drug	through	the	different	skin	layers,	and	K	is	a	partition	coefficient	
Figure 1: Schematic	representation	of	the	transport	processes	involved	in	drug	release	from	the	formulation	up	to	its	
uptake	through	the	dermal	capillaries	[6].
4Advances	in	Textile	Engineering
between	the	skin	layers	and	the	drug	formulation	(typically	K=	concentration	in	skin	layer/
concentration	in	vehicle).
1.2.2. Release mechanisms from vehicles and substrates 
	 The	release	of	an	active	agent	in	a	non-erodible	core-shell	system	can	show	different	
profiles	of	delivery.	In	Figure	2,	four	possible	theoretical	curves	(A,	B,	C	and	D)	show	the	
global	behaviors	of	the	release	phenomena	in	different	situations.
	 Curve	A	shows	a	perfect	release	profile.	It	shows	a	system	where	the	rate	of	delivery	is	
controlled	by	the	diffusion	of	the	active	agent	molecules	through	the	external	membrane.	The	
rate	of	release	depends	strongly	on	the	internal-external	concentration	gradient.
	 If	 there	 exist	 some	molecules	 that	 are	 retained	 in	 the	 shell,	 then	 a	 lag-time	 on	 the	
release	will	be	obtained.	Then,	there	will	be	two	controlling	steps	and	diffusion	will	undergo	a	
transitional	intermediate	state.	Curve	A	in	Figure	2	displays	a	system	with	no	lag-time.	When	
the	encapsulated	material	migrates	to	the	external	membrane	of	the	microcapsule,	there	will	
be	a	“burst-effect,”	as	shown	by	line	B.	
	 If	the	microcapsule	acts	as	a	microsphere	(the	entire	amount	of	active	agent	is	distributed	
in	the	polymer	matrix),	the	Higuchi	equation	is	useful	up	to	60%	release.	In	this	case,	a	plot	
of	percent	released	versus	square	root	of	time	is	linear,	as	shown	by	line	C.	First-order	release	
is	represented	by	curve	D.	The	curve	will	be	linear	when	the	Log	of	the	percentage	of	core	
material	remaining	in	the	capsule	is	plotted	versus	time	[25].
	 The	main	aim	is	to	apply	a	mathematic	model	based	on	the	phenomenology	involved,	to	
explain	in vitro	permeation	experiments	with	a	biofunctional	textile	using	different	molecules,	
as	tracers.	
	 The	Korsenmeyer-Peppas,	equation	(2),	can	be	used	to	account	for	the	coupled	effects	of	
Figure 2: Theoretical	 release	 curves	 expected	 for	 different	 types	 of	 non-erodible	 delivery	 systems.	A,	Membrane	
reservoir-type	free	of	lag	time	and	burst	effects;	B,	same	as	A,	with	burst	effects;	C,	matrix	or	monolithic	sphere	with	
square	root	time-release;	D,	system	with	first-order	release	[24].
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Fickian	diffusion	and	viscoelastic	relaxation	in	polymer	systems	by	including	both	processes:
	 	 	 	 (2)	
	 Where	Mt	is	the	amount	of	drug	released	at	time	t,	M∞	is	the	maximal	amount	of	the	
released	 drug	 at	 infinite	 time,	 k	 is	 the	 rate	 constant	 of	 drug	 release,	 and	 n	 is	 a	 diffusional	
exponent	that	depends	on	the	system	geometry,	and	the	value	of	n	is	indicative	of	the	release	
mechanism	of	the	active	agent.
 Eq	(2)	has	been	used	frequently	in	the	literature	to	describe	the	relative	importance	of	
transport	mechanisms	as	shown	in	Table	1	[26-32].
	 Historically,	the	first	mathematical	model	of	drug	permeation	through	the	skin	was	that	
proposed	by	Higuchi.	Since	the	establishment	of	the	model,	many	other	authors	have	conducted	
excellent	research	studies	on	this	topic,	developing	several	models	based	on	changes	in	active	
principle	concentrations
	 The	transport	in	polymeric	organized	systems	can	be	described	by	Fick’s	second	Law,	so	
the	diffusion	of	the	active	agent	can	be	assumed	as	a	plane	surface	for	short	times	of	liberation,	
using	the	Higuchi	equation	(eq.	4)	for	to	calculate	the	apparent	diffusion	coefficient,	using	the	
approximation	of	eq.(3),	where	D	is	the	apparent	diffusion	coefficient	of	drug	release,	and	δ	is	
the	width	of	the	planar	matrix.
	 	 	 	 (3)
	 The	most	widely	used	model	 to	describe	drug	release	 from	matrices	 is	derived	from	
Higuchi	for	a	plane	geometry,	which	is	applicable	for	systems	of	different	shapes	as	well.
    (4)
2. Active Principles used in Micro/Nanoencapsulation for textiles 
2.1. Polymers
	 Encapsulation	 is	one	of	 the	 techniques	used	 to	 apply	 substances	 to	 textiles	 [33,	34].	
Biodegradable	polymer	micro-	or	nanoparticles	are	of	great	interest	as	drug	delivery	systems	
because	of	 their	ability	 to	be	 reabsorbed	by	 the	body.	Synthetic	aliphatic	 linear	polyesters,	
such	as	poly-ε-caprolactone	 (PCL),	 are	often	used	 in	biomedical	 applications	 [35]	because	
n Drug Delivery Systems
n	≤	0.5 Fickian	Diffusion	Mechanism
0.5	<	n	<	1 Anomalous	Diffusion
n	≥	1 Non-Fickian	Diffusion	Mechanism	(zero-order	model)
Table 1: Drug	delivery	models	based	on	the	parameter	n.
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they	are	biocompatible,	non-toxic	and	have	certain	advantages	over	other	polymers	such	as	
PLA	(poly	lactic	acid):	(a)	the	polymers	are	more	stable	under	ambient	conditions;	(b)	they	are	
significantly	less	expensive	and,	(c)	they	are	readily	available	in	large	quantities	[36].	
2.2. Ibuprofen 
	 Ibuprofen	 was	 used	 as	 active	 principle-tracer.	 Ibuprofen	 is	 an	 anti-inflammatory	
steroid.	It	is	used	to	relieve	symptoms	of	arthritis,	primary	dysmenorrhoea,	fever,	and	as	an	
analgesic,	especially	where	there	is	an	inflammatory	component.	Ibuprofen	appears	to	have	the	
lowest	incidence	of	gastrointestinal	reactions	adverse	of	all	non-selective	non-steroidal	anti-
inflammatory	drugs	(NSAIDs).	However,	this	only	occurs	at	lower	doses	of	ibuprofen	because	
the	usually	advisable	maximum	daily	dose	 is	1,200	mg.	Adverse	effects	 include	dyspepsia,	
nausea,	ulcers/bleeding	gastrointestinal,	 increased	hepatic	enzymes,	diarrhoea,	constipation,	
epistaxis,	headache,	dizziness,	priapism,	rash,	salt	and	fluid	retention,	and	hypertension.
2.3. Caffeine 
	 Caffeine	is	other	active	principle	used	to	prepare	biofunctional	cotton	textiles.	Caffeine	
was	selected	given	its	use	 in	several	specific	 therapies	and	its	widespread	use	 in	cosmetics	
because	of	its	stimulating	activity	on	fat	metabolism	(anti-cellulite	action)	[37-39].	Especial	
emphasis	was	placed	on	the	release	of	this	active	principle	from	the	formulations	and	from	the	
cotton	fabrics	and	on	its	transdermal	delivery	in	order	to	reach	the	target	compartment	of	the	
skin.
2.4. Gallic Acid (GA)
	 GA	was	selected	and	incorporated	into	polyamide	(PA)	through	microspheres	prepared	
from	poly-ε-caprolactone	(PCL).	Gallic	acid	(GA)	was	chosen	as	the	active	agent	to	obtain	a	
biofunctional	textile	with	antioxidant	properties.	Antioxidants	are	natural	agents	that	are	used	
to	prevent	 the	 external	 aggression	of	oxidative	 stress	 in	human	beings.	The	 route	 to	 apply	
different	 compounds	 is	 clearly	 through	 the	 skin.	When	 topically	 applied,	 these	 exogenous	
antioxidants	have	been	demonstrated	to	diminish	the	effects	of	free	radicals	by	using	defense	
mechanisms	similar	or	complementary	to	those	of	endogenous	antioxidants	[40-41].
2.5. In vitro drug release experimental results
	 After	GA	encapsulation	and	application	onto	cotton	(CO)	and	polyamide	(PA)	fabrics,	
the	results	obtained	are	shown	in	Figure 3.
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Figure 3: SEM	micrographs	of	PCL-Microspheres	with	GA.	A)	Cotton	fabric	(x1000).	B)	Polyamide	fabric	(x1000) 
 CO	fibers	allow	 the	microspheres	 to	be	placed	 in	corners	and	spaces	which	create	a	
proper	fiber	structure	and	PA	accepts	 the	microspheres	between	fibers.	Visually,	PA	retains	
more	microspheres	 than	CO.	This	 is	 in	 accordance	with	 the	higher	 amount	of	dry	product	
present	in	the	PA	fabric.
	 To	perform	the	analysis	of	the	mechanism	of	the	drug	delivery	system,	the	treated	fabric	
samples	were	submerged	into	a	semi-infinite	bath	of	physiological	saline,	and	every	x	minutes,	
a	bath	aliquote	was	picked	up	and	analysed	by	HPLC.
 In	Figure 4,	it	can	be	seen	that	PA	releases	GA	more	quickly	than	CO,	and	PA	reaches	
equilibrium	before	CO.	
	 Using	Eq.	(2)	on	 the	values	of	 the	first	steps	(Figure 4),	 the	exponent	n	 is	obtained,	
which	is	indicative	of	the	drug	delivery	mechanism	(Table 2).
3. Lípids as Vehicles for Skin Treatment 
	 Liposomes	 are	 vesicles	made	 up	 of	 lipids	 that	 can	 encapsulate	 different	 compounds	
for	 application	onto	 textiles.	Liposomes	have	been	used	 as	models	 for	 complex	biological	
membranes	 in	 biophysical	 and	 medical	 research	 owing	 to	 their	 lipid	 bilayer	 structural	
Figure 4: Kinetic	release	of	GA	(M)	applied	on	textile	fabrics	in	a	bath	of	serum	at	37°C.
Table 2: n	values	obtained	from	fitting	drug	release	experimental	data	by	equation	2.
n Drug delivery system
CO	fabric 0.46 Fickian	diffusion
PA	fabric 0.63 Anomalous	diffusion
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similarity.	Moreover,	they	have	been	the	subject	of	numerous	studies	given	their	importance	
as	microencapsulation	devices	for	drug	delivery	and	their	applications	in	cosmetics	[41-45].	
In	recent	years,	liposomes	have	been	used	in	the	textile	industry	as	dyeing	auxiliaries,	mainly	
for	wool	dyeing	[46,47]	or	as	a	dispersing	auxiliary	for	disperse	dyes	[48,49].	
	 Wool	 is	a	keratinized	 tissue	whose	 internal	 lipids	have	been	extracted	and	analyzed.	
These	lipids	are	rich	in	cholesterol,	free	fatty	acids,	cholesterol	sulphate	and	ceramides	and	they	
resemble	those	found	in	membranes	of	other	keratinized	tissues	such	as	human	hair	or	stratum 
corneum	from	skin,	because	of	their	capacity	to	form	stable	bilayer	structures.	Accordingly,	
IWL	could	be	regarded	as	a	new	and	natural	form	to	encapsulate	different	active	agents	or	as	
active	agents	for	skin	care	[50,	52].
3.1. In vitro percutaneous absorption experiments (Franz diffusion cells) and cutaneous 
effectivity
	 For	these	studies,	pig	skin	was	used	with	a	thickness	of	approximately	500	±	50	μm.	
Skin	discs	with	a	2.5cm	inner	diameter	were	prepared	and	fitted	into	static	Franz-type	diffusion	
cells.
	 A	control	skin	disc	(without	product	application	on	the	skin	surface)	was	used	to	rule	
out	possible	interferences	in	the	analysis	by	HPLC-UV.	According	to	the	OECD	methodology	
[5],	the	skin	penetration	studies	were	performed	for	24	h	of	close	contact	between	the	textile	
and	the	skin.	To	increase	the	contact	pressure	between	the	textile	fabric	and	skin,	permeation	
experiments	were	also	carried	out	by	placing	a	steel	cylinder	on	the	textile-skin	substrate	at	
a	constant	pressure	in	accordance	with	standard	conditions	(125	g/cm2)	(ISO	105-E04,	1996)
(see	Figure 5).
	 After	the	exposure	time,	the	receptor	fluid	was	collected,	the	fabrics	were	removed	from	
the	skin	surface	and	collected	together	with	the	top	of	the	cell.	The	stratum corneum	of	the	skin	
was	removed	using	adhesive.	The	epidermis	was	separated	from	the	dermis	after	heating	the	
skin	[53].	
	 The	 efficacy	 of	 the	 biofunctional	 textiles	 in	 close	 contact	with	 skin	was	 studied	 by	
Figure 5:	Diagram	of	in vitro	percutaneous	absorption	experiments.
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measuring	changes	in	transepidermal	water	loss	(TEWL)	as	an	index	of	skin	barrier	repair,	
whereas	the	water-holding	capacity	was	measured	as	changes	in	skin	capacitance	[54].	
	 Skin	tape	stripping	is	an	 in vivo	methodology	used	to	demonstrate	the	penetration	of	
the	principle	into	the	outermost	layers	of	volunteer	forearm	skin	[55,	56].	This	is	a	minimally	
invasive	 technique	 to	 sequentially	 remove	 SC	 by	 the	 repeated	 application	 of	 appropriate	
adhesive	tapes	[57].	
	 Using	these	methodologies,	it	was	concluded	that	liposomes,	especially	those	prepared	
with	IWL,	were	suitable	vehicles	for	applying	a	given	active	principle	onto	textiles.
3.2. Gallic Acid (GA) encapsulated in lipid structures
	 GA	was	encapsulated	into	liposomes	and	applied	to	different	fabrics,	cotton,	polyamide,	
polyester,	acrylic	and	wool,	using	bath	exhaustion	and	the	pad-dry	processes.	GA	absorption-
desorption	behavior	of	the	different	textiles	was	compared	using	the	two	methodologies	(by	
weight	difference	and	by	extraction	and	detection).
	 Also,	GA	was	encapsulated	in	liposomes	and	in	mixed	micelles	for	application	to	cotton	
and	polyamide.	GA	absorption-desorption	behavior	of	the	textiles	was	also	determined	using	
the	two	impregnation	methods.
3.2.1. Liposome/Mixed Micelle Preparation for Gallic Acid
	 Liposomes	of	4%	of	Emulmetik	900	 (PC)	and	2%	GA	were	prepared	using	 the	film	
hydration	method	reported	elsewhere	[58].	Mixed	micelles	(30	wt%	of	surfactant,	4	wt%	of	
PC	and	2	wt%	GA)	were	prepared	solubilizing	all	compounds	in	distilled	water;	solubilisation	
was	performed	by	gently	shaking	until	clear	solutions	were	obtained.	
	 Particle	sizes	of	liposomes	and	mixed	micelles	were	measured	by	using	Dynamic	Light	
Scattering	(DLS),	to	determine	size	distribution,	polydispersity	index	and	zeta	potential	of	the	
two	lipidic	structures.	
	 To	quantify	 the	GA	entrapped	in	 the	vesicles,	 liposome	formulation	was	precipitated	
and	separated	from	the	supernatant	by	centrifugation.	The	efficacy	entrapment	percentage	of	
GA	in	liposomes	was	determined	with	the	amount	of	the	active	principle	present	in	the	whole	
liposome	solution	as	well	as	in	the	supernatant,	using	a	GA	calibration	curve.
3.2.2. Textile application and absorption/desorption process. 
	 The	application	of	liposomes	or	the	mixed	micelles	onto	the	fabrics	was	performed	by	
bath	exhaustion	and	the	foulard	padding	process	[59].	
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	 Liposomes	 and	 mixed	 micelles	 were	 also	 applied	 to	 textiles	 in	 triplicate	 with	 bath	
exhaustion,	 liquor	 ratio	1/5,	at	60ºC	for	60	min	with	manual	 stirring	every	10	minutes.	To	
quantify	the	amount	of	liposomes	or	mixed	micelles	absorbed	into	the	fabrics,	the	dry	samples	
were	weighted	before	and	after	24h	application	under	standard	ambient	conditions	(20±2ºC	
and	65±5%	relative	humidity).
	 Treated	 fabrics	 were	 washed	 in	 three	 different	 water	 baths	 at	 room	 temperature.	 In	
all	cases,	the	dry	samples	were	weighted	before	and	after	24h	of	the	washing	process	under	
standard	ambient	conditions.	The	first	washing	step	was	performed	with	deionised	water	(1/5	
liquor	ratio)	for	5	min	with	magnetic	stirring.	A	second	wash	was	carried	out	with	deionised	
water	(1/10	liquor	ratio)	for	5	min	with	magnetic	stirring,	and	the	third	wash,	with	deionised	
water	(1/25	liquor	ratio)	for	5	min	with	magnetic	stirring.	Particle	size	and	zeta	potential	were	
measured	in	the	baths	after	the	exhaustion	treatment	and	in	the	baths	after	the	first	and	third	
washings	as	described	for	the	initial	formulations.
	 The	higher	substantivity	of	the	phospholipid	liposomes	for	some	fibers	like	PAC,	PA	
and	WO	was	clearly	demonstrated	by	an	absorption	level	higher	than	15%	for	all	these	fibers.	
Desorption	with	water	was	 also	 evaluated	 for	 all	 the	 treated	 fabrics.	Results	 of	 remaining	
liposome	in	percentage	are	also	described	in	Table 3.
 As	in	the	case	of	the	padding	process,	the	highest	desorption	was	obtained	for	the	most	
synthetic	PAC	and	PES	fabrics,	 followed	by	CO	and	WO.	The	highest	 retained	amount	of	
liposomes	was	obtained	for	the	PA	fabric.	
	 Both	liposomes	and	the	textile	fibers	are	usually	electrically	charged.	They	are	surrounded	
by	a	cloud	of	ions	which	carry	an	equal	and	opposite	charge.	The	zeta	potential	is	the	voltage	
difference	 between	 the	 droplet	 surface	 and	 the	 liquid	 beyond	 the	 charge	 cloud.	 Initial	GA	
liposome	formulation	applied	to	textiles	has	an	acidic	pH	of	3.3	with	a	zeta	potential	of	-4mV.	
However,	 in	 the	washing	baths	 the	pH	rises	 to	around	5.0	and	 the	zeta	potential	 to	around	
-50mV.	The	increase	in	the	water	layers	around	a	negative	charge	due	to	dilution	renders	the	
zeta	potential	more	negative.	Moreover,	the	nature	of	the	chemical	dissociable	groups	in	the	
textile	fiber	surface	induces	a	negative	zeta	potential	of	the	fibers,	see	Table	4	[60,61].
Table 3: Percentage	of	liposome	absorbed	and	desorbed	on	the	different	fabrics,	CO,	PA,	PES,	PAC	and	WO	using	the	
bath	exhaustion	methodology.	(%	owf:	percentage	over	weight	of	fiber)
Ini. weightg Fin. weight % owf Weight 1st washing % owf Weight total washing % owf
CO 2.00±0.01 10.99±0.39 7.32±2.43 5.58±0.39
PA 2.05±0.04 16.34±1.23 12.73±1.94 7.31±0.64
PES 2.07±0.01 14.05±1.15 9.64±1.53 2.05±0.50
PAC 1.98±0.06 17.44±1.09 13.20±0.93 4.25±0.33
WO 2.04±0.04 17.15±0.90 12.95±1.05 6.17±0.51
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CO	is	the	most	hydrophilic	fiber,	its	higher	swelling	capacity	yielding	to	smaller	zeta	potential	
values	 than	 the	 hydrophobic	 fibers.	 PAC	 and,	 especially	 PES	 fibers	 contain	 sulfonic	 and	
carboxylic	groups,	respectively,	contributing	to	the	most	negative	zeta	potential.	Because	WO	
has	 carboxylic	 and	 amino	 groups	 near	 the	 surface,	 negative	 or	 positive	 zeta	 potentials	 are	
found	when	the	pH	is	over	or	under	its	isoelectric	point	3.5.	PA	has	a	moderate	hydrophilicity,	
inferior	to	cotton	but	superior	to	PES	and	PAC.	Moreover,	its	weakly	basic	amino	groups	and	
weakly	acidic	carboxylic	acid	groups	give	rise	to	the	ionic	properties	similar	to	WO.
	 In	the	absorption	process	at	pH	3.3,	most	of	the	fabrics	have	a	neutral	or	cationic	character	
with	the	result	that	absorption	is	similar.	In	the	washing	baths	at	pH	≈	5	and	more	negative	zeta	
potential,	textiles	also	have	higher	negative	values.	The	desorption	of	the	PES	and	PAC	(the	
fibers	with	the	most	negative	zeta	potential)	is	therefore	about	85%	and	75%,	respectively.	By	
contrast,	desorption	of	WO,	PA	and	CO	(the	fibers	with	the	least	negative	zeta	potential)	is	
about	65%,	55%	and	50%,	respectively.	The	highest	fixation	properties	demonstrated	by	the	
lowest	desorption	of	PA	and	CO,	together	with	the	highest	comfort	properties	of	these	fibers	
when	in	contact	with	the	skin,	endorse	their	application	as	cosmetic	biofunctional	textiles.	
	 In	 mixed	 micelles,	 the	 two	 constituent	 phospholipids	 and	 the	 surfactant	 agent	 are	
structured	together	in	small	micelles,	giving	rise	to	a	transparent	solution.	However,	dilution	of	
mixed	micelles	promotes	the	separation	of	the	surfactant	and	the	phospholipids	with	formation	
of	liposomes.	This	results	in	a	large	increase	in	size,	giving	rise	to	a	turbid	solution	[62].	The	
absorption	of	micelles	by	textiles	could	be	maintained	after	a	washing	process	because	of	an	
expected	increase	in	size	of	the	vehicles	inside	the	fiber.	This	could	enhance	the	fixation	in	
textiles	with	less	desorption	as	occurs	in	the	skin	[63,64].	
	 This	was	expected,	owing	to	liposome	formation	with	dilution.	Besides,	zeta	potential	is	
always	negative	with	small	values	for	the	two	concentrated	formulations	around	-4mV	(Table	
5).	They	 increase	with	 dilution	 in	 absolute	 value	 to	 -20mV	 for	 the	mixed	micelles	 and	 to	
-50mV	for	liposomes.	These	increases	in	negatively	charged	are	due	to	the	repulsion	charges	
in	the	dilutions,	which	increase	the	colloid	stability.
Table 4:	Z-potentials	of	textile	fibers	in	aqueous	neutral	media	(83).
CO PA PES PAC WO
Pot	Z.	(mV) -33 -42 -74 -47 -45
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	 As	in	the	liposome	formulation,	the	application	of	the	active	agent	vehiculized	in	mixed	
micelles	(36%	of	dry	product	and	2%	GA)	to	the	textile	substrates,	CO	and	PA	was	performed	
by	the	foulard	process	in	an	attempt	to	achieve	a	pick-up	of	approximately	90-100%.	
	 When	mixed	micelles	were	applied	to	the	fabrics,	there	were	differences	of	about	35%	
between	the	calculated	amount	of	product	impregnated	(34-35%)	and	the	product	found	in	the	
fabric	after	heating	at	the	Stenter	(22-23%).	This	could	mean	that	the	surfactant,	which	is	the	
main	component	of	the	mixed	micelles,	has	higher	substantivity	for	water	than	for	the	textiles.	
CO	and	PA	incorporate	almost	the	same	amount	of	product	(about	23%)	which	is	much	higher	
than	the	amount	of	product	absorbed	with	liposomes	(see	Table 3).	Desorption	with	water	was	
also	evaluated	for	the	two	fabrics.	Results	of	remaining	mixed	micelles	in	percentage	are	also	
described	in	Table 6	and	are	graphically	represented	in	Figure	6.	For	comparison,	the	results	
obtained	with	liposomes	are	also	shown.
 The	same	mixed	micelles	formulation	was	applied	to	cotton	and	PA	by	bath	exhaustion	
as	described	in	the	experimental	section.	The	initial	weights	with	the	percentages	of	dry	product	
calculated	by	weight	difference	between	dry	initial	fabric	and	dry	fabric	after	bath	exhaustion	
are	shown	in	Table 7.
Table 5: Mean	size,	polydispersity	index	and	Z	potential	of	initial	liposome	and	mixed	micelle	formulations	and	their	
dilutions.
Formulation Mean Size (nm) Polydispers. Index Z-Potential (mV)
Liposome	4%	PC 717.40±56.25 0.74±0,03 -4.3±0.30
Liposome	0.4%	PC 407.47±24.07 0.79±0,03 -46.3±1.08
Liposome	0.2%	PC 367.80±	8.51 0.84±0,10 -49.2±0.90
Liposome	0.1%	PC 395.07±	28.84 0.60±0,14 -57.1±0.20
Mix.	Micelle	4%	PC 8.05±	0.08 0.13±0.02 -4.07±0.01
Mix.	Micelle	0.4%	PC 8.23±0.17 0.10±0,01 -8.69±1.28
Mix.	Micelle	0.2%	PC 10.53±0.06 0.14±0.05 -20.47±1.17
Mix.	Micelle	0.1%	PC 55.35±0.08 0.09±0.01 -19.13±0.29
Table 6: Percentage	(%	owf)	of	mixed	micelles	absorbed	and	desorbed	on	CO	and	PA	using	the	foulard	process.
Ini. weight g Pick-uptot.% lip%
Fin. weight
% owf
Weight 1st washing.
% owf
Weight total washings.
% owf
CO 2.01±0.10 95.28±3.22	34.3 22.23±1.50 7.07±1.0 1.11±0.13
PA 2.06±0.01 97.6	±0.5	35.1 23.05±0.63 7.44±0.6 0.26±0.17
Table 7: Percentage	of	mixed	micelles	absorbed	and	desorbed	on	CO	and	PA	using	the	bath	exhaustion	methodology.
Ini. weight
g
Fin. weight
%
Weight 1st w.
%
Weight total w.
%
CO 2.05±0.04 35,43±2.73 12.72±0.44 2.42±0.06
PA 2.08±0.02 40,14±4.23 18.29±1.98 3.91±0.11
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 When	mixed	micelles	were	applied	to	the	fabrics	by	bath	exhaustion,	as	in	the	liposome	
treatments,	 higher	 absorption	was	obtained	 for	 the	 two	 fabrics	with	 respect	 to	 the	pad-dry	
process,	with	higher	substantivity	for	PA.	The	higher	temperature	of	bath	exhaustion	(60ºC)	
with	respect	to	the	foulard	process	(30ºC)	could	account	for	this.	Desorption	with	water	was	also	
evaluated	for	all	fabrics.	Results	of	remaining	mixed	micelles	in	percentage	are	also	described	
in	Table 7	and	are	represented	in	Figure 6	including	the	results	obtained	with	liposomes.
 As	in	the	case	of	the	foulard	process,	despite	the	high	absorption,	considerably	higher	
desorption	was	obtained	for	the	mixed	micelles	treated	fabrics	with	respect	to	the	liposome	
treated	fabrics.	Moreover,	PA	presents	higher	absorption	and	less	desorption	than	CO	in	the	
case	of	 liposomes	and	mixed	micelles	 treatments.	 Interaction	of	 lecithin	with	CO	has	been	
reported	 to	 be	mainly	 at	 the	 surface	 through	 a	 coating	 layer,	whereas	 interaction	with	 PA	
occurs	in	the	interior	of	the	fiber	[65].
	 The	higher	absorption	of	mixed	micelles	in	CO	and	especially	in	PA	could	be	due	to	
the	presence	of	Oramix	 in	30%.	The	 increase	 in	particle	 size	with	dilution	 in	 the	washing	
baths,	which	could	attain	50-100nm,	does	not	prevent	desorption.	By	contrast,	a	large	amount	
of	desorption	occurs	 in	mixed	micelles	 treated	fabrics.	Desorption	of	PA	and	CO	liposome	
treated	fibers	was	about	50%,	whereas	desorption	of	PA	and	CO	mixed	micelles	treated	fibers	
attained	90%.	The	size	of	the	lipid	structures	of	liposomes	and	mixed	micelles	was	evaluated	
in	the	initial	and	washing	baths	of	the	exhaustion	treatments	(Table 8)	to	determine	its	possible	
influence	on	product	desorption.
Figure 6: Absorption	and	desorption	of	total	product	(GA	in	liposome	or	mixed	micelles)	applied	to	cotton	and	polyamide	
by	bath	exhaustion.
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 The	increase	in	particle	size	of	these	structures	(see	Table	8)	did	not	prevent	their	exit	
from	the	fibers	with	less	desorption	as	expected.	By	contrast,	desorption	was	maximum.	This	
could	be	due	to	a	higher	permeability	of	textiles	compared	with	human	skin	in	which	this	effect	
was	not	observed	[63,64].
 The	lower	amount	of	GA,	both	real	and	theoretical,	in	CO	and	PA	treated	with	mixed	
micelles	with	 respect	 to	 those	 treated	with	 liposomes	should	be	noted.	The	 real	amount	of	
GA	evaluated	by	HPLC	in	CO	fibers	is	always	lower	for	the	two	vehicles	than	the	amount	
calculated.	This	is	not	the	case	for	the	PA	fiber.	These	phenomena	suggest	a	low	substantivity	
Table 8: Size	(Z-Average)	and	Polydispersity	Index	(Pdl)	of	different	baths	of	CO	and	PA	subjected	to	bath	exhaustion	
with	liposomes	and	mixed	micelles.
Treatment Analyzed Bath
Size (Z-Average) 
Diameter (nm)
PdI
Cotton/Liposomes
Initial	Bath 525.6±26.1 0.68±0.03
Bath	after	exhaustion	treatment 375.3±64.6 0.51±0.12
Bath	after	1st	water	washing	(10	ml) 474.3±32.2 0.68±0.20
Bath	after	3rd	water	washing	(50	ml) 623.5±18.8 0.52±0.03
Cotton/Mixed Micelles
Initial	Bath 6.9±	0.8 0.98±0.04
Bath	after	exhaustion	treatment 102.2±30.9 0.98±0.03
Bath	after	1st	water	washing	(10	ml) 206.7±76.5 0.34±0.12
Bath	after	3rd	water	washing	(50	ml) 211.0±38.2 0.31±0.02
Polyamide/Liposomes
Initial	Bath 525.6±26.0 0.68±0.03
Bath	after	exhaustion	treatment 460.6±76.4 0.45±0.01
Bath	after	1st	water	washing	(10	ml) 510.0±53.2 0.88±0.21
Bath	after	3rd	water	washing	(50	ml) 660.3±31.9 0.49±0.04
Polyamide/Mixed Micelles
Initial	Bath 6.6±0.8 0.97±0.04
Bath	after	exhaustion	treatment 157.2±81.7 0.62±0.17
Bath	after	1st	water	washing	(10	ml) 257.6±97.9 0.05±0.12
Bath	after	3rd	water	washing	(50	ml) 166.9±89.5 0.34±0.07
Figure 4: Real	and	theoretical	GA	percentages	of	treated	and	washed	textiles.
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for	the	GA	for	cotton	and	a	much	greater	substantivity	for	PA.	It	can	therefore	be	concluded	
that	the	vehiculization	efficiency	of	liposomes	with	respect	to	mixed	micelles	is	always	greater	
for	polyamide	than	for	CO.	Thus	a	biofunctional	textile	with	more	than	5%	of	GA	is	obtained	
even	after	three	consecutive	washings.
4. Electrosupun Nanofibers as Biomedical Devices 
4.1. Introduction
	 Over	the	past	20	years,	the	interactions	of	the	fields	of	polymer	and	materials	science	
with	 the	 pharmaceutical	 industry	 have	 resulted	 in	 the	 development	 of	what	 are	 known	 as	
drug	delivery	systems	(DDSs),	or	controlled-release	systems	[66-69].	Drug	delivery	systems	
can	be	classified	according	to	the	mechanism	that	controls	the	release	of	the	drug	[70],	such	
as	 diffusion-controlled	 systems,	 chemically	 controlled	 systems,	 solvent-activated	 systems,	
modulated-release	systems	and	bioerodible-release	systems	[69-74].
	 One	of	the	most	promising	biodegradable	polymers	for	use	in	bioerodible-release	systems	
is	poly(lactic	acid)	(PLA),	Fig	5,	because	of	its	mechanical	and	biological	properties.
	 PLA	is	a	thermoplastic	polyester	derived	from	renewable	resources,	such	as	corn	starch.	
PLA	has	a	hydrolytic	degradation	mechanism,	and	it	is	capable	of	degrading	into	innocuous	
lactic	acid	and	then	into	CO2	and	water,	which	are	absorbed	by	the	body.	PLA	is	used	in	medical	
implants	in	the	form	of	screws,	pins,	rods	and	as	a	mesh	[75-77].	Depending	on	the	exact	type	
used,	PLA	degrades	in	the	body	within	6	months	to	2	years	[77].	This	gradual	degradation	is	
desirable	for	a	support	structure	because	it	gradually	transfers	the	load	to	the	body	as	the	organ	
heals.
 Here,	 the	 properties	 of	 a	 different	 drug-delivery	 system,	which	 consists	 of	 different	
nanofiber	membrane	configurations,	were	examined.	The	membrane	configuration	was	based	
on	 sandwiching	 the	 drug	 between	 two	 adjacent	 layers	 of	 electrospun	 PLA	membranes	 to	
determine	 the	mass	 transport	 behavior	 of	 the	 drug	 through	 different	 polymeric	membrane	
configurations.
	 Similar	studies	have	been	conducted	by	Fied	et	al.	[78]	with	the	purpose	of	developing	
ultrafiltration	membranes.	 Tiemessen	 et	 al.	 [79]	 have	 also	 described	 a	 so-called	 occlusion	
simulation	 model	 based	 on	 sandwiching	 the	 stratum corneum	 between	 sticky	 silicone	
membranes	to	provide	a	means	for	simulating	skin	penetration	under	occlusion.
Figure 5:	Chemical	structure	of	PLA
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	 The	electrospun	PLA	membranes	were	shown	to	provide	a	useful	mechanical	support	for	
the	drug.	The	initial	studies	on	the	sandwich	model	also	revealed	that	this	model	provides	an	
elegant	means	to	kinetically	control	the	water	uptake	by	the	drug.	Although	the	PLA	membrane	
is	biodegradable	or	erodible	(i.e.,	a	system	that	disintegrates	over	time),	this	phenomenon	can	
be	irrelevant	when	the	entire	drug	is	released	before	the	dissolution	of	the	polymer	becomes	
important.	Therefore,	the	membranes	could	be	considered	non-erodible.	
	 Therefore,	this	new	system	can	be	directly	used	in	the	prophylactic	period	of	patients	
who	 recently	underwent	 an	operation,	when	 in situ	 application	 is	 required.	 In	 some	cases,	
this	particular	membrane	can	act	not	only	as	a	carrier	but	also	as	cavity	filler	with	therapeutic	
agents.
	 Here,	 the	polymeric	 solution	used	 to	produce	nanofibers	was	obtained	by	dissolving	
10%	of	the	solution	weight	of	poly(lactic	acid)	in	dichloromethane	under	constant	magnetic	
agitation	and	at	a	constant	room	temperature	of	23-25	°C.	The	magnetic	agitation	remained	
constant	until	the	PLA	was	completely	dissolved,	which	was	indicated	by	the	solution	becoming	
translucent	 and	when	no	 solid	 particles	were	 detected.	Complete	 dissolution	was	 achieved	
after	1	hour	of	agitation.
	 To	conduct	the	experiment,	a	high	voltage	power	supply,	a	spinneret	(a	capillary	tube	
with	very	small	diameter)	and	a	grounded	collector	plate	(a	plate	usually	composed	of	metal)	
were	required,	as	seen	in	Figure 6.
 During	the	electrospinning	process,	a	strong	electrostatic	field	is	applied	to	a	polymer	
solution	held	 in	a	syringe	with	a	capillary	outlet.	A	pendent-shaped	droplet	of	 the	polymer	
solution	from	the	capillary	outlet	is	deformed	into	a	Taylor	cone	[80]	by	the	electrostatic	field.	
When	the	voltage	surpasses	a	threshold	value,	the	electric	force	overcomes	the	surface	tension	
of	the	droplet	and	a	charged	jet	of	the	solution	is	ejected	from	the	tip	of	the	Taylor	cone.	As	
the	jet	moves	toward	a	collecting	metal	screen	(counter	electrode),	the	solvent	evaporates	and	
a	non-woven	fabric	mat	is	formed	on	the	screen	[81].	The	process	can	be	seen	in	Figure 7.
Figure 6: Electrospinning	device	containing	all	essential	elements:	high	voltage,	spinneret,	metal	collector	
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4.2. Experimental results of Nanofibers formation
	 When	 applying	 the	 former	 conditions	 specified,	 PLA	 nanofibers	 are	 formed,	 as	 the	
following	figures	show.
Figure 7: Electrospinning	of	PLA	under	optimal	conditions
Figure 8:	SEM	of	PLA	fibers	under	optimal	high	voltage	conditions	(order	of	magnitude	1000	x).
Figure 9: SEM	of	PLA	with	bead	defects;	order	of	magnitude	250x
Figure 10:	SEM	of	PLA	fibers	with	increasing	flow	rate;	order	of	magnitude	4000x.
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4.3. Sandwich configuration with Ibuprofen or Caffeine
	 Ibuprofen,	 or	 caffeine,	 was	 placed	 between	 two	 adjacent	 layers	 of	 the	 polymeric	
membranes.	When	the	first	layer	of	the	electrospun	membrane	was	dried	and	solidified,	the	
drug,	which	was	 in	 a	 dried	medium,	was	 evenly	 dispersed	 on	 the	membrane	 surface.	The	
amount	 of	 drug	was	 controlled	 using	 an	 analytical	 balance.	After	 placing	 the	 drug	 on	 the	
membrane	surface,	a	second	membrane	layer	was	electrospun	over	the	first	layer	to	cover	the	
drug	[82].
4.4. Drug-Delivery Mechanisms
	 The	capability	of	the	polymeric	membrane	to	deliver	the	drug	was	determined	through	
triplicate	measurements	of	the	drug	release	kinetics	into	a	fluid	phase.
	 The	drug	release	kinetics	were	determined	using	batch	methods	for	membranes	operating	
in	different	conditions,	such	as	membranes	obtained	after	different	electrospinning	periods	(5,	
10	and	20	minutes)	and	sandwich	membranes	with	different	drug	amounts	(5,	10	and	15	mg).	
For	each	operating	condition,	the	experiment	was	repeated	3	times.
	 To	perform	the	experiment,	the	sandwich	membranes	were	placed	between	concentric	
rings	in	a	metallic	tambour	system,	as	shown	in	Figure	13,	to	ensure	uniform	mass	transfer	
along the	surface	of	 the	membrane	from	the	solid	phase	 to	 the	fluid	phase	and	 to	so	avoid	
bending	stress.
Figure 11:	SEM	of	porous	PLA	fiber	due	to	high	room	humidity
Figure 12: SEM	of	nanofibers	produced	by	optimized	electrospinning	process;	order	of	magnitude	15000x.
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 After	adjusting	the	sandwich	membranes	in	the	metallic	tambour	system,	they	were	placed	
in	a	covered	container	with	100	mL	of	physiological	serum	as	the	fluid	phase,	with	a	pH	7.4.	
The	containers	prepared	for	the	analyses	were	maintained	in	a	bath	with	a	constant	temperature	
of	37°C.	The	samples	were	taken	for	analysis	at	regular	time	intervals,	and	the	concentrations	
of	drug	released	into	the	fluid	phase	were	determined	through	spectrophotometric	techniques	
in	a	Shimadzu	UV-2401	PC	UV-vis	spectrophotometer	with	a	wavelength	of	263	nm.
4.5. Controlled Drug Release Mathematical Modeling
	 The	results	obtained	from	the	kinetics	tests	were	used	for	the	mathematical	modeling	of	
the	controlled	drug	release,	following	the	approach	explained	before	in	Immich	et	al.[83]	and	
in	1.2.2.	
4.6. Scanning Electron Microscopy (SEM)
	 The	 surface	 morphologies	 and	 thicknesses	 (δ)	 of	 the	 polymeric	 membranes	 were	
examined	using	a	scanning	electron	microscope	(JEOL/JSM-5610).	After	the	samples	were	
dried	overnight	at	room	temperature,	each	specimen	was	sputtered-coated	with	gold	powder	
before	being	examined	with	the	SEM.	For	the	thickness	measurement,	3	different	regions	of	the	
transversal	area	of	the	membrane	were	measured,	and	the	average	value	of	these	measurements	
was	used.
	 The	membrane	 thickness	was	 determined	 for	 the	 PLA	membranes	 obtained	 after	 5,	
10	 and	20	minutes	 of	 electrospinning	with	different	 amounts	 of	 ibuprofen.	The	 results	 are	
presented	in	Table 9.
Figure 13:	Mass	transfer	configuration	device	on	the	drug-delivery	experiment
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	 The	differences	in	the	morphologies	of	the	PLA	membranes	with	different	electrospinning	
time	 intervals	 were	 analyzed	 and	 the	 difference	 in	 the	 amount	 of	 fibers	 in	 each	 obtained	
membrane	is	noticeable.	In	the	PLA	membrane	obtained	after	5	minutes	of	electrospinning,	it	
can	be	seen	empty	spaces	among	the	fibers.	These	empty	spaces	facilitate	mass	transference	of	
the	fluid	phase	through	the	membrane,	which	is	readily	conducive	to	drug	release.	When	there	
is	an	increase	in	the	amount	of	fibers	and	consequently,	a	reduction	in	the	amount	of	empty	
space,	the	molecular	mobility	becomes	difficult	and	consequently,	it	reduces	mass	transport	
through	the	membrane.
	 The	diameter	of	the	fiber	in	a	pure	membrane	obtained	after	20	minutes	of	electrospinning	
(without	the	drug)	was	also	measured	using	SEM,	and	the	average	diameter	is	approximately	
150	nm	when	disregarding	the	bead	effect.	
4.7. Ibuptofen delivery from PLA electrospun membrane
	 The	influence	of	the	membrane	thickness	on	the	release	kinetics	of	ibuprofen	through	
PLA	membranes	was	studied	at	an	initial	drug	amount	of	5	mg	(Figure 14).
 
	 Although	the	PLA	membrane	is	biodegradable	or	erodible,	in	this	study,	the	phenomenon	
Table 9: Thickness	of	PLA	membranes	for	different	ibuprofen	amounts.
Electrospinning time(min) Ibuprofen amount (mg) Membrane thickness (mm)
5 5 0.0662
5 10 0.0926
5 15 0.1190
10 5 0.0927
10 10 0.1130
10 15 0.1423
20 5 0.1192
20 10 0.1424
20 15 0.1655
Figure 14: Kinetics	of	ibuprofen	delivery	from	PLA	membranes	after	5	minutes	electrospinning	After	the	initial	burst,	
the	polymer	structure	swells,	stabilizes	and	traps	the	drug.	The	result	is	a	continuous	and	slower	sustained	release	process.
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was	negligible	because	the	entire	drug	had	already	been	released	before	the	dissolution	of	the	
polymer	became	important.	Therefore,	 the	membranes	were	considered	 to	be	non-erodible.	
Figure	14	presents	kinetics	behavior	with	a	more	intense	initial	burst,	which	leads	to	a	release	
of	approximately	0.05	g/L	of	ibuprofen	(100	%	of	initial	drug	concentration)	during	the	first	
stage	of	the	drug	delivery.	
	 More	controlled	release	processes	are	observed	in	kinetics	presented	in	Figures	15	and	
16,	with	a	less	intense	burst	effect	and	an	initial	drug	release	of	approximately	0.03	g/L	(30%	
of	initial	drug	concentration)	and	0.02	g/L	(13%	of	initial	drug	concentration),	respectively.	
This	decrease	in	the	burst	effect	intensity	is	due	to	an	increase	in	membrane	thickness	after	10	
and	20	minutes	of	electrospinning,	which	delayed	mass	transference	through	the	polymeric	
membrane	to	the	external	fluid	phase.
 In	addition	to	the	decrease	of	the	burst	effect	in	drug	release	for	the	membrane	obtained	
after	20	minutes	of	electrospinning,	an	increase	in	the	pseudo-equilibrium	time	of	total	drug	
release	was	also	observed	due	to	the	membrane	thickness,	which	is	considerably	greater	than	
that	of	the	membrane	obtained	after	5	minutes	of	electrospinning.	This	thicker	membrane	also	
restrains	and	controls	drug	mobility	and	transport	through	the	membrane.
Figure 15:	Kinetics	of	Ibuprofen	delivery	from	PLA	membranes	after	10	minutes	electrospinning
Figure 16:	Kinetics	of	ibuprofen	delivery	from	PLA	membranes	after	20	minutes	electrospinning
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	 The	amount	of	ibuprofen	within	the	membrane	is	also	important	when	determining	the	
time	required	for	the	total	release	of	the	drug.	When	the	amount	of	ibuprofen	increases	from	5	
to	10	mg,	the	time	required	for	the	total	release	of	the	drug	increases	by	72%	on	average.	There	
is	no	significant	increase	in	time	for	the	total	release	of	the	drug	when	the	amount	of	ibuprofen	
increases	from	10	to	15	mg.	Membranes	with	10	and	15	mg	of	ibuprofen	have	similar	behavior	
during	the	releasing	process.
	 Because	the	kinetics	curves	for	the	release	of	ibuprofen,	which	are	illustrated	in	Figures	
14,	15	and	16,	exhibit	the	typical	behavior	for	reservoir-type	membranes,	it	can	be	assumed	
that	 the	drug	 transport	mechanism	through	 these	membranes	 is	usually	a	solution-diffusion	
mechanism.	Though,	 this	 is	not	sufficient	 to	prove	the	mechanism	of	drug	release.	For	that	
reason,	 the	 releasing	mechanism	(n)	of	 ibuprofen	was	calculated,	according	 to	Power	Law	
equation	(2)	[83].
 The	 releasing	mechanism	presented	 in	Table 10,	 for	polymeric	membranes	obtained	
after	5	minutes	of	electrospinning,	do	not	describe	any	established	mechanism	of	drug	release.	
It	means	the	mechanism	of	release	is	neither	a	diffusion-controlled	drug	release	(n=0.5)	nor	a	
swelling-controlled	drug	release	(n=1),	where	the	relaxation	process	of	the	macromolecules	
occurring	upon	water	imbibition	into	the	system	is	the	rate	controlling	step.	Here,	the	reason	
for	the	release	of	ibuprofen	must	be	the	large	porosity	of	the	thin	5	minute	membrane	that	does	
not	restrict	the	molecules	of	ibuprofen	from	passing	through.
	 However,	 for	 membranes	 obtained	 after	 10	 and	 20	 minutes	 of	 electrospinning,	 the	
exponent	n	takes	a	value	of	0.5	or	very	close	to	0.5.	It	indicates	that	diffusion	is	the	mechanism	
controlling	 the	 release	 of	 ibuprofen.	Therefore,	 drug	 transport	 initially	 occurs	 through	 the	
dissolution	of	 the	drug	 through	 the	membrane,	which	 is	 followed	by	diffusion	 through	 the	
same	membrane	and	desorption	to	the	other	side	of	the	membrane.	Considering	that	the	release	
of	ibuprofen	is	controlled	by	diffusion,	it	is	possible	to	apply	the	classical	Higuchi	equation	
(eq.	3),	to	determine	the	mass	transport	coefficient,	and	then	the	approach	of	Fick’s	second	law	
Table 10: Mechanism	of	drug	release	for	PLA	membranes.
Electrospinning time (min) Ibuprofen amount (mg) n (releasing mechanism)
5 5 0.18
5 10 0.30
5 15 0.31
10 5 0.22
10 10 0.50
10 15 0.50
20 5 0.25
20 10 0.40
20 15 0.40
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to	determine	the	apparent	diffusivity	of	ibuprofen	through	the	PLA	membranes	obtained	after	
10	and	20	minutes	of	electrospinning.
 
 The	data	presented	in	Table 11	shows	that	the	mass	transport	coefficient,	KH,	(equation	
(4))	for	the	release	of	ibuprofen	through	electrospinning	membranes,	decreased	when	membrane	
thickness	is	increased	(from	10	to	20	min.	electrospinning).	This	result	is	due	to	the	reinforcement	
of	fibers,	which	become	denser	and	not	easily	penetrable.	This	fiber	 reinforcement	reduces	
the	empty	spaces	available	for	ibuprofen	particle	mobility,	which	restrains	its	transference	to	
the	external	medium.	Increasing	the	drug	concentration	further	decreases	the	available	empty	
spaces	for	mass	transference,	which	consequently	decreases	the	mass	transport	coefficient.
	 Table	11	also	shows	the	diffusivity	(D)	values,	which	appear	to	increase	for	the	10	min.	
electrospinning	membrane	when	the	initial	drug	concentration	is	increased.	
	 Increasing	the	electrospinning	time	from	10	to	20	min.	produces	even	denser	membranes	
that	 are	 full	 of	 fibers	with	 a	 compact	 internal	 structure	 and	 less	 empty	 spaces	 for	 particle	
mobility	and	transport.	Therefore,	increasing	the	ibuprofen	concentration	fills	even	more	of	
the	empty	spaces	in	the	membrane,	which	decreases	the	possibility	of	internal	transport	and	
consequently	decreases	the	mass	transport	coefficient	and	restrains	the	drug	delivery,	as	shown	
in	Table 11.	
	 Unlike	the	10	min.	electrospinning	membrane,	the	diffusivity	of	ibuprofen	through	the	
20	min.	electrospinning	membrane	is	practically	constant	with	increasing	drug	concentration,	
as	 the	 variation	 in	 the	 diffusivity	 values	 is	 insignificant.	 This	 is	 due	 to	 the	 uniformity	 of	
membrane	thickness.	The	minor	variation	in	diffusivity	shown	for	the	20	min.	electrospinning	
membrane	could	be	attributed	to	theoretical	fitting	uncertainty.	Here,	it	is	possible	to	maintain	
the	percentage	of	drug	release	disregarding	the	amount	of	drug	in	the	reservoir.	The	average	
value	of	diffusivity	shown	in	Table 11	is	2.5	E-08	cm2/s,	in	accordance	with	the	common	range	
of	drug	diffusivities	in	various	membranes	[84,85].
Table 11: Drug	release	parameters	for	PLA	membranes	obtained	after	10	and	20	minutes	of	electrospinning.
Electrospinning time 
(min)
Ibuprofen amount 
(mg) KH Diffusivity (cm
2/s)
10 5 0.033 1.8395E-08
10 10 0.030 2.2564E-08
10 15 0.029 3.3436E-08
20 5 0.028 2.1899E-08
20 10 0.026 2.6895E-08
20 15 0.023 2.8468E-08
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